Daily Stock Opinions and Ratings

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Opinions

Peter Hodson Stressgen Biotechnologies Corp SSB-T BUY May 12, 2003

They are far enough into their trials that investors are now paying more attention. Relatively cheap. Management is OK.

Peter Hodson

Unknown

Unlock Rating

$1.900

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

BUY ON WEAKNESS

A speculative stock. Has to move through the regulatory gateway. Meets a lot of technical resistance at the $1.81 level. Try to pick up near its support level of $1.25.

DON'T BUY

On their watch list. Lost a lot of maney last year.

BUY

Very volatile. Developing a product for HBV (a sexually transmitted disease), which has a large market. In phase two. Has a partnership with Roach and has enough cash to probably last into 2005.

DON'T BUY

Have restructured and will need more money.

TRADE

A field that you have to be really wary of. Many of them have a very high burn rate. Although their trials were fast tracked, this does not necessarily mean continued success.

TOP PICK

Holds this stock personally. Risky could double.

PAST TOP PICK

(A Top Pick June 14/04. Down 56%.) They continue to lose money. They'll have to get something through their pipeline quickly that deals with cancer. Doesn't look good.

DON'T BUY

Trying to raise $50 million which is equivalent/more than their entire market cap.

DON'T BUY

A lottery ticket! The company has gone into orphan status. Have disappointed investors many, many times. They keep needing money. Very risky.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Peter Hodson Stressgen Biotechnologies Corp SSB-T BUY May 12, 2003

You might be interested:

Stressgen Biotechnologies Corp(SSB-T)

Stressgen Biotechnologies Corp(SSB-T)

Stressgen Biotechnologies Corp(SSB-T)

Stressgen Biotechnologies Corp(SSB-T)

Stressgen Biotechnologies Corp(SSB-T)

Stressgen Biotechnologies Corp(SSB-T)

Stressgen Biotechnologies Corp(SSB-T)

Stressgen Biotechnologies Corp(SSB-T)

Stressgen Biotechnologies Corp(SSB-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Kim Bolton

Stockchase Insights

Jim Cramer - Mad Money

Paul Harris, CFA

The Panic-Proof Portfolio (Stockchase Research)